vs
Apellis Pharmaceuticals, Inc.（APLS）与CENTURY CASINOS INC（CNTY）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是CENTURY CASINOS INC的1.4倍（$199.9M vs $138.0M），CENTURY CASINOS INC净利率更高（-13.0% vs -29.5%，领先16.5%），CENTURY CASINOS INC同比增速更快（0.2% vs -5.9%），CENTURY CASINOS INC自由现金流更多（$-4.7M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 0.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
世纪赌场（Century Casinos）是一家博彩企业，总部位于美国科罗拉多州科罗拉多斯普林斯，主营赌场娱乐相关业务，在北美及其他地区运营多处博彩娱乐场所。
APLS vs CNTY — 直观对比
营收规模更大
APLS
是对方的1.4倍
$138.0M
营收增速更快
CNTY
高出6.1%
-5.9%
净利率更高
CNTY
高出16.5%
-29.5%
自由现金流更多
CNTY
多$9.6M
$-14.3M
两年增速更快
APLS
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $138.0M |
| 净利润 | $-59.0M | $-17.9M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 7.6% |
| 净利率 | -29.5% | -13.0% |
| 营收同比 | -5.9% | 0.2% |
| 净利润同比 | -62.2% | 80.1% |
| 每股收益（稀释后） | $-0.40 | $-0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSCNTY
| Q4 25 | $199.9M | $138.0M | ||
| Q3 25 | $458.6M | $153.7M | ||
| Q2 25 | $178.5M | $150.8M | ||
| Q1 25 | $166.8M | $130.4M | ||
| Q4 24 | $212.5M | $137.8M | ||
| Q3 24 | $196.8M | $155.7M | ||
| Q2 24 | $199.7M | $146.4M | ||
| Q1 24 | $172.3M | $136.0M |
净利润APLSCNTY
| Q4 25 | $-59.0M | $-17.9M | ||
| Q3 25 | $215.7M | $-10.5M | ||
| Q2 25 | $-42.2M | $-12.3M | ||
| Q1 25 | $-92.2M | $-20.6M | ||
| Q4 24 | $-36.4M | $-90.3M | ||
| Q3 24 | $-57.4M | $-8.1M | ||
| Q2 24 | $-37.7M | $-41.6M | ||
| Q1 24 | $-66.4M | $-13.5M |
营业利润率APLSCNTY
| Q4 25 | -25.6% | 7.6% | ||
| Q3 25 | 48.7% | 11.1% | ||
| Q2 25 | -18.6% | 11.0% | ||
| Q1 25 | -50.0% | 5.5% | ||
| Q4 24 | -12.3% | -45.5% | ||
| Q3 24 | -24.0% | 11.5% | ||
| Q2 24 | -14.7% | 9.7% | ||
| Q1 24 | -36.0% | 6.1% |
净利率APLSCNTY
| Q4 25 | -29.5% | -13.0% | ||
| Q3 25 | 47.0% | -6.9% | ||
| Q2 25 | -23.6% | -8.2% | ||
| Q1 25 | -55.3% | -15.8% | ||
| Q4 24 | -17.1% | -65.6% | ||
| Q3 24 | -29.2% | -5.2% | ||
| Q2 24 | -18.9% | -28.4% | ||
| Q1 24 | -38.5% | -10.0% |
每股收益（稀释后）APLSCNTY
| Q4 25 | $-0.40 | $-0.62 | ||
| Q3 25 | $1.67 | $-0.35 | ||
| Q2 25 | $-0.33 | $-0.40 | ||
| Q1 25 | $-0.74 | $-0.67 | ||
| Q4 24 | $-0.30 | $-2.95 | ||
| Q3 24 | $-0.46 | $-0.26 | ||
| Q2 24 | $-0.30 | $-1.36 | ||
| Q1 24 | $-0.54 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $68.9M |
| 总债务越低越好 | — | $328.9M |
| 股东权益账面价值 | $370.1M | $-97.7M |
| 总资产 | $1.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSCNTY
| Q4 25 | $466.2M | $68.9M | ||
| Q3 25 | $479.2M | $77.7M | ||
| Q2 25 | $370.0M | $85.5M | ||
| Q1 25 | $358.4M | $84.7M | ||
| Q4 24 | $411.3M | $98.8M | ||
| Q3 24 | $396.9M | $118.8M | ||
| Q2 24 | $360.1M | $123.2M | ||
| Q1 24 | $325.9M | $136.5M |
总债务APLSCNTY
| Q4 25 | — | $328.9M | ||
| Q3 25 | — | $329.3M | ||
| Q2 25 | — | $328.0M | ||
| Q1 25 | — | $328.8M | ||
| Q4 24 | — | $328.2M | ||
| Q3 24 | — | $327.5M | ||
| Q2 24 | — | $328.8M | ||
| Q1 24 | $93.1M | $328.5M |
股东权益APLSCNTY
| Q4 25 | $370.1M | $-97.7M | ||
| Q3 25 | $401.2M | $-78.6M | ||
| Q2 25 | $156.3M | $-66.9M | ||
| Q1 25 | $164.2M | $-54.3M | ||
| Q4 24 | $228.5M | $-34.7M | ||
| Q3 24 | $237.1M | $56.8M | ||
| Q2 24 | $264.3M | $64.6M | ||
| Q1 24 | $266.7M | $106.1M |
总资产APLSCNTY
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $821.4M | $1.2B | ||
| Q1 25 | $807.3M | $1.2B | ||
| Q4 24 | $885.1M | $1.2B | ||
| Q3 24 | $901.9M | $1.3B | ||
| Q2 24 | $904.5M | $1.3B | ||
| Q1 24 | $831.9M | $1.3B |
负债/权益比APLSCNTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.77× | ||
| Q2 24 | — | 5.09× | ||
| Q1 24 | 0.35× | 3.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $-114.0K |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-4.7M |
| 自由现金流率自由现金流/营收 | -7.1% | -3.4% |
| 资本支出强度资本支出/营收 | 0.1% | 3.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-15.3M |
8季度趋势，按日历期对齐
经营现金流APLSCNTY
| Q4 25 | $-14.2M | $-114.0K | ||
| Q3 25 | $108.5M | $144.0K | ||
| Q2 25 | $4.4M | $11.3M | ||
| Q1 25 | $-53.4M | $-4.6M | ||
| Q4 24 | $19.4M | $-2.3M | ||
| Q3 24 | $34.1M | $7.4M | ||
| Q2 24 | $-8.3M | $3.0M | ||
| Q1 24 | $-133.0M | $-11.5M |
自由现金流APLSCNTY
| Q4 25 | $-14.3M | $-4.7M | ||
| Q3 25 | $108.3M | $-4.7M | ||
| Q2 25 | $4.4M | $5.5M | ||
| Q1 25 | $-53.4M | $-11.3M | ||
| Q4 24 | $19.3M | $-16.9M | ||
| Q3 24 | — | $-2.8M | ||
| Q2 24 | $-8.4M | $-12.9M | ||
| Q1 24 | $-133.3M | $-29.9M |
自由现金流率APLSCNTY
| Q4 25 | -7.1% | -3.4% | ||
| Q3 25 | 23.6% | -3.1% | ||
| Q2 25 | 2.5% | 3.6% | ||
| Q1 25 | -32.0% | -8.7% | ||
| Q4 24 | 9.1% | -12.3% | ||
| Q3 24 | — | -1.8% | ||
| Q2 24 | -4.2% | -8.8% | ||
| Q1 24 | -77.3% | -22.0% |
资本支出强度APLSCNTY
| Q4 25 | 0.1% | 3.3% | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.0% | 5.1% | ||
| Q4 24 | 0.0% | 10.7% | ||
| Q3 24 | 0.0% | 6.6% | ||
| Q2 24 | 0.0% | 10.9% | ||
| Q1 24 | 0.2% | 13.5% |
现金转化率APLSCNTY
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
CNTY
| Gaming | $103.9M | 75% |
| Food And Beverage | $13.2M | 10% |
| Hotel | $10.5M | 8% |
| Other | $5.2M | 4% |
| Pari Mutuel And Sports Betting And Igaming | $5.2M | 4% |
